FDA
approval
· 2024-11-05
FDA Approved: TOPIRAMATE — Original Application (Vitruvias Therapeutics, Inc.)
Summary
FDA approves Vitruvias Therapeutics' generic Topiramate through an Original Application (ANDA), expanding access as a generic option for epilepsy and migraine p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TOPIRAMATE (TOPIRAMATE)